EurekAlert (press release)Cancer stem cells, allies of the tumor and enemies of the patientEurekAlert (press release)They want to uncover the physiological mechanisms of the cancer stem cell, the arch-enemy of the patient because it is responsible for … Continue reading
|
International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
GlobeNewswire (press release) CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth … |
|
International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
Nasdaq CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth … |
|
International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson’s Disease Clinical Trial
Nasdaq CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the eighth … |
Genetic Literacy Project |
Targeted evolution: Why are we so afraid of CRISPR gene editing?
Genetic Literacy Project The potential applications of CRISPR are enormous. It’s the closest we’ve ever come to a cure for cancer. We’ve already been able to cure HIV infection in animal models, and even in human cell cultures, by removing the viral genes that insert … |
|
Sorrento Therapeutics Autologous Anti-CEA CAR–T Cell Therapy for Liver Metastases Demonstrates Therapeutic …
GlobeNewswire (press release) SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), cellular therapy focused subsidiary, TNK Therapeutics, Inc. (“TNK”), and Surefire Medical, Inc., announced today initial results from the Hepatic … Sorrento (SRNE) Says Anti-CEA CAR–T Cell Therapy for Liver Metastases Demonstrates Therapeutic Activity in Stage …StreetInsider.com Sorrento’s liver artery-infused CAR–T cells showed positive effect in early-stage studySeeking Alpha |